Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
Cambrian Biopharma
company
About
Cambrian is a distributed development company building therapeutics to lengthen health span.
- 11 - 50
Details
- Last Funding Type
- Series A
- Industries
- Biopharma,Biotechnology,Life Science
- Founded date
- Jan 1, 2019
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Cambrian Biopharma is building the medicines that will modernize healthcare in the 21st century – therapeutics to lengthen healthspan, the period of life spent in good health.As a Distributed Development Company (or DisCo), Cambrian is advancing multiple scientific breakthroughs, each targeting a biological driver of aging. Our approach is to develop interventions that treat specific diseases first, then deploy them as preventative medicines to improve quality of life/overall quality of life as we age.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
$160M
Cambrian Biopharma has raised a total of
$160M
in funding over 2 rounds. Their latest funding was raised on
Oct 26, 2021 from a Series C round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Oct 26, 2021 | Series C | $100M | 2 | — | — | Detail |
| Feb 9, 2021 | Series B | $60M | 1 | — | — | Detail |
| Nov 1, 2019 | Series A | — | 1 | — | — | Detail |
Investments
Number of Investments
Number of Lead Investments
1
0
Cambrian Biopharma has made 1 investments. Their most recent investment was on
Apr 13, 2021, when Arcellx raised 0.
Investors
Number of Lead Investors
Number of Investors
—
3
Cambrian Biopharma is funded by 3 investors.
Korify Capital
and Kliwla Family Office AG
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Korify Capital
|
— | Series C |
Kliwla Family Office AG
|
— | Series C |
NJF Capital
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
